Cellular reprograming implicated in model of Alzheimer's disease
Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease.
Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease.
Success rate is comparable to that of highly trained scientists performing the process manually.
MIT study suggests a new approach to developing treatments for Alzheimer’s disease.
Discovery of how amyloids bind metal ions sheds light on protein function.
Digital pen plus speedy data analysis developed at MIT and tested at Lahey Hospital improves a classic test that helps detect cognitive impairment.
Noninvasive technique reduces beta amyloid plaques in mouse models of Alzheimer’s disease.
Picower Institute director awarded for her research on brain development, neurological disorders, and Alzheimer’s disease.
Study finds a complex series of molecular, cellular, circuit and network-level changes contribute to the progression of Alzheimer's.
Over half a century at MIT, Corkin made lasting contributions to the biology of memory and cognitive disorders.
Neuroscientists retrieve missing memories in mice with early Alzheimer’s symptoms.
Enhanced-sensitivity NMR could reveal new clues to how proteins fold.
Combining MRI and other data helps machine-learning systems predict effects of neurodegenerative disease.
Team from MIT's Computer Science and Artificial Intelligence Lab detects dementia using AI and a digital pen.
MIT’s Picower Institute to partner on four projects with Case Western Reserve University.
Study of epigenomic modifications reveals immune basis of Alzheimer's disease.